SEARCH RESULTS FOR:

Mining
Canada

Ontario Mining 2018 Pre-Release Edition

Mining
Cote d’Ivoire
Ghana
MACIG

Jeff Quartermaine

CEO & Managing Director, PERSEUS MINING
MACIG 2018 PRE-RELEASE 2
Perseus is an ASX and TSX-listed company based in Perth with a focus on West Africa.
Petrochemicals & Chemicals
India

India: Potential to Proceed

India Chemicals 2018 Pre-Release Edition
Expectation increases as development gathers pace.
Mexico
Petrochemicals & Chemicals

A Brave New World: Energy Reform and the Mexican Chemical Industry

Mexico Petrochemicals and Chemicals 2018 APLA Pre-Release
Mexico’s energy reform, national elections, the shale revolution in USA and Trump’s renegotiations of NAFTA all spell interesting times for Mexico’s chemical industry.
Petrochemicals & Chemicals
Singapore

Saad Haroon

HEAD OF SEEDCARE APAC, SYNGENTA
Singapore Chemicals 2018
Seedcare APAC are seeking to promote seed treatment in Asia where it is not well understood.
Petrochemicals & Chemicals
Singapore

David Ryan & Dave Shepherd

HEAD OF COMMERCIAL EXCELLENCE, APAC; LEADER, DIGITAL INNOVATION LAB & DIGITAL DELIVERY; INNOVATION LAB LEAD, SYNGENTA
Singapore Chemicals 2018
Syngenta’s Digital Innovation Lab in Singapore looks at how digital initiatives can increase smallholder productivity.
Petrochemicals & Chemicals
India

Sudhir Shenoy

CEO, DOW INDIA – DOW CHEMICAL
India Chemicals 2018 Pre-Release Edition
Dow Chemical in India speaks to GBR about its operations and the benefits that Sadara will bring.
Petrochemicals & Chemicals
India

India Chemicals 2018 Pre-Release Edition

Aerospace
France

Eric Pisani

CEO, SINTEX NP
Auvergne-Rhône-Alpes Aerospace 2018
Sintex is looking to expand its offering of thermoplastic composites to serve the aerospace sector worldwide.
Petrochemicals & Chemicals
India

H. S. Karangle

DIRECTOR GENERAL, INDIAN CHEMICAL COUNCIL
GBR speaks to the Indian Chemical Council about the prospects for the industry.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

United States Life Sciences 2025 - Digital Interactive

Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
MORE PREVIOUSLY PUBLISHED

PARTNER EVENTS

SEE ALL